EMJ GOLD

Filter Advertise With Us

Pills being placed in a person's hand

First patients enroll in Bundibugyo Ebola treatment trial

The PARTNERS trial has launched in the DRC as the country continues to battle an outbreak that has already led to more than 1,400 cases.

GSK office building

GSK to acquire Nuvalent for $10.6bn ahead of patent cliff

The purchase, GSK’s biggest in over a decade, includes two late-stage lung cancer drugs primed for FDA approval.

Gavi commits $50m to Bundibugyo Ebola virus vaccines

Gavi has committed $50m to efforts towards vaccine approval for the Ebola virus outbreak in the Democratic Republic of the Congo and Uganda, caused by the Bundibugyo virus.

Injectable pen

Boehringer posts mixed obesity drug phase 3 results

Despite the positive efficacy data, investor attention has turned to survodutide’s tolerability profile.

White DNA helix on blue background

FDA unveils new plan for genome therapy editing

The guidance allows sponsors to build on data generated from previous R&D programmes.

Person holding a wax model of ovaries in their palms

NHS rolls out first new ovarian cancer drug in 20 years

The targeted therapy will be available for patients with epithelial ovarian, peritoneal, or fallopian tube cancers.

Month in pharma news, explained

Month in pharma news, explained – May 2026

From a potential breakthrough in pancreatic cancer to fresh Ebola concerns and more FDA leadership turmoil, discover the most-read stories.

Trial points to breakthrough in cancer metastasis prevention

A phase 2a study has revealed encouraging early evidence for cancer metastasis prevention, with fewer metastatic recurrences and no metastasis-related deaths in treated patients.

Two scientists in a lab

CEPI pledges $61.8m to fast-track Ebola vaccines

There is no licensed vaccine for the current Bundibugyo strain, with three vaccine makers hoping they hold the key.

Loading posts...

« Previous 1 2 3 4 5 … 54 Next »